14-3-3 proteins in Lewy bodies in Parkinson disease and diffuse Lewy body disease brains

被引:140
作者
Kawamoto, Y
Akiguchi, I
Nakamura, S
Honjyo, Y
Shibasaki, H
Budka, H
机构
[1] Kyoto Univ, Fac Med, Dept Neurol, Sakyo Ku, Kyoto 6068507, Japan
[2] Univ Vienna, Inst Neurol, A-1097 Vienna, Austria
关键词
14-3-3; proteins; alpha-synuclein; diffuse Lewy body disease; Lewy bodies; Parkinson disease;
D O I
10.1093/jnen/61.3.245
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Several components of Lewy bodies have been identified. but the precise mechanism responsible for the formation of Lewy bodies remains undetermined. The 14-3-3 protein family is involved in numerous signal transduction pathways and interacts with alpha-synuclein, which is a major constituent of Lewy bodies. To elucidate the role of 14-3-3 proteins in neuro-degenerative disorders associated with Lewy bodies. we performed immunohistochemical studies on 14-3-3 in brains from 5 elderly control subjects and from 10 patients with Parkinson disease (PD) or diffuse Lewy body disease (DLBD). In the normal controls, 14-3-3-like immunoreactivity, was mainly observed in the neuronal somata and processes in various cortical and subcortical regions. In the PD and DLBD cases, a similar immunostaining pattern was found and immunoreactivity was generally spared in the surviving neurons from the severely affected regions. In addition, both classical and cortical Lewy bodies were intensely immunolabeled and some dystrophic neurites were also immunoreactive for 14-3-3. Our results suggest that 14-3-3 proteins may be associated with Lewy body formation and may play an important role in the pathogenesis of PD and DLBD.
引用
收藏
页码:245 / 253
页数:9
相关论文
共 48 条
  • [1] 14-3-3 PROTEINS - A HIGHLY CONSERVED, WIDESPREAD FAMILY OF EUKARYOTIC PROTEINS
    AITKEN, A
    COLLINGE, DB
    VANHEUSDEN, BPH
    ISOBE, T
    ROSEBOOM, PH
    ROSENFELD, G
    SOLL, J
    [J]. TRENDS IN BIOCHEMICAL SCIENCES, 1992, 17 (12) : 498 - 501
  • [2] Baba M, 1998, AM J PATHOL, V152, P879
  • [3] PURIFICATION, PROPERTIES, AND IMMUNOHISTOCHEMICAL LOCALIZATION OF HUMAN-BRAIN 14-3-3 PROTEIN
    BOSTON, PF
    JACKSON, P
    KYNOCH, PAM
    THOMPSON, RJ
    [J]. JOURNAL OF NEUROCHEMISTRY, 1982, 38 (05) : 1466 - 1474
  • [4] HUMAN 14-3-3 PROTEIN - RADIOIMMUNOASSAY, TISSUE DISTRIBUTION, AND CEREBROSPINAL-FLUID LEVELS IN PATIENTS WITH NEUROLOGICAL DISORDERS
    BOSTON, PF
    JACKSON, P
    THOMPSON, RJ
    [J]. JOURNAL OF NEUROCHEMISTRY, 1982, 38 (05) : 1475 - 1482
  • [5] DIFFUSE LEWY BODY DISEASE - CLINICAL-FEATURES IN 15 CASES
    BYRNE, EJ
    LENNOX, G
    LOWE, J
    GODWINAUSTEN, RB
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1989, 52 (06) : 709 - 717
  • [6] Accelerated in vitro fibril formation by a mutant α-synuclein linked to early-onset Parkinson disease
    Conway, KA
    Harper, JD
    Lansbury, PT
    [J]. NATURE MEDICINE, 1998, 4 (11) : 1318 - 1320
  • [7] Synphilin-1 associates with α-synuclein and promotes the formation of cytosolic inclusions
    Engelender, S
    Kaminsky, Z
    Guo, X
    Sharp, AH
    Amaravi, RK
    Kleiderlein, JJ
    Margolis, RL
    Troncoso, JC
    Lanahan, AA
    Worley, PF
    Dawson, VL
    Dawson, TM
    Ross, CA
    [J]. NATURE GENETICS, 1999, 22 (01) : 110 - 114
  • [8] REACTION OF LEWY BODIES WITH ANTIBODIES TO PHOSPHORYLATED AND NONPHOSPHORYLATED NEUROFILAMENTS
    FORNO, LS
    STERNBERGER, LA
    STERNBERGER, NH
    STREFLING, AM
    SWANSON, K
    ENG, LF
    [J]. NEUROSCIENCE LETTERS, 1986, 64 (03) : 253 - 258
  • [9] 14-3-3 proteins: Structure, function, and regulation
    Fu, HA
    Subramanian, RR
    Masters, SC
    [J]. ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2000, 40 : 617 - 647
  • [10] Mutant and wild type human α-synucleins assemble into elongated filaments with distinct morphologies in vitro
    Giasson, BI
    Uryu, K
    Trojanowski, JQ
    Lee, VMY
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (12) : 7619 - 7622